Total item
Cart Subtotal
$0.00 Biological Activity
BAY 57-1293 is a potent helicase primase inhibitor. BAY 57-1293 inhibits replication of herpes simplex virus (HSV) type 1 and type 2 in the nanomolar range in vitro by abrogating the enzymatic activity of the viral primase-helicase complex.
Targets
| helicase primase | ||||
| In vitro | DMSO | 80 mg/mL (198.76 mM) | |
| Water | <1 mg/mL (<1 mM) | ||
| Ethanol | <1 mg/mL (<1 mM) | ||
|
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
|||
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 0.1 mM | 24.85 mL | 124.23 mL | 248.45 mL |
| 0.5 mM | 4.97 mL | 24.85 mL | 49.69 mL |
| 1 mM | 2.48 mL | 12.42 mL | 24.85 mL |
| 5 mM | 0.5 mL | 2.48 mL | 4.97 mL |
*The above data is based on the productmolecular weight 402.49. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
| Catalog Num | A13324 |
|---|---|
| Actions | Inhibitor |
| M. Wt | 402.49 |
| Formula | C18H18N4O3S2 |
| Solubility | DMSO |
| Purity | >98% |
| Storage | at -20°C 3 years Powder |
| CAS No. | 348086-71-5 |
| Synonyms | BAY-57-1293; BAY57-1293; BAY 57-1293 |
| SMILES | CC1=C(SC(=N1)N(C)C(=O)CC2=CC=C(C=C2)C3=CC=CC=N3)S(=O)(=O)N |
Product Tags
Product Questions
Product Questions
No Questions
Keywords:buy BAY57-1293 | BAY57-1293 Supplier | purchase | cost | manufacturer | order | distributor | buy 348086-71-5| 348086-71-5 Supplier | purchase 348086-71-5 | 348086-71-5 cost | 348086-71-5 manufacturer | order 348086-71-5 | 348086-71-5 distributor
Contact information
United StatesAdooq Bioscience
Toll Free: (866) 930-6790
Fax: +1-323-606-8156
Email: [email protected]
Not your Region? View all Distributors
Adooq Quality Guarantee
We promise all products perform as described.